Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.

The Korean journal of internal medicine

Volumn 14, Issue 2, 1999, Pages 15-19

  Ozyilkan, O ^a   Yalcintas U ^a   Baskan S ^a  

^a Bayindir Medical Center   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFOPERAZONE; CILASTATIN; IMIPENEM; SULBACTAM;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; FEVER; HUMAN; MALE; MIDDLE AGED; NEOPLASM; NEUTROPENIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIKACIN; BACTEREMIA; CEFOPERAZONE; CILASTATIN; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HUMANS; IMIPENEM; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; SULBACTAM;

EID: 0033163523     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.1999.14.2.15     Document Type: Article

References (0)